251 related articles for article (PubMed ID: 17714892)
1. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
Oosegi T; Onishi H; Machida Y
Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Onishi H; Oosegi T; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832
[TBL] [Abstract][Full Text] [Related]
3. Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Oosegi T; Onishi H; Machida Y
Eur J Pharm Biopharm; 2008 Feb; 68(2):260-6. PubMed ID: 17703928
[TBL] [Abstract][Full Text] [Related]
4. Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres.
Onishi H; Oosegi T; Machida Y; McGinity JW
Drug Dev Ind Pharm; 2007 Aug; 33(8):848-54. PubMed ID: 17729102
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone.
Onishi H; Saito Y; Sasatsu M; Machida Y
Int J Pharm; 2011 May; 410(1-2):17-22. PubMed ID: 21397670
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Simple Eudragit Microparticles Loaded with Prednisolone and Eudragit-Coated Chitosan-Succinyl-Prednisolone Conjugate Microparticles: Part II. In Vivo Evaluation of Efficacy, Toxicity, and Biodisposition Characteristics.
Onishi H; Kikuchi H
Int J Mol Sci; 2015 Nov; 16(11):26125-36. PubMed ID: 26540041
[TBL] [Abstract][Full Text] [Related]
7. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
8. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
9. Eudragit-coated chitosan-tripterygium glycoside conjugate microspheres alleviate DSS-induced experimental colitis by inhibiting the TLR4/NF-κB signaling pathway.
Xue G; Xiong H; Wang S; Fu Y; Xie Y
Biomed Pharmacother; 2023 Feb; 158():114194. PubMed ID: 36916404
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: comparison of simple and conjugate microspheres.
Onishi H; Oosegi T; Machida Y; McGinity JW
Drug Dev Ind Pharm; 2005 Aug; 31(7):597-605. PubMed ID: 16207606
[TBL] [Abstract][Full Text] [Related]
12. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
[TBL] [Abstract][Full Text] [Related]
13. Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis.
Kietzmann D; Moulari B; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2010 Oct; 76(2):290-5. PubMed ID: 20600885
[TBL] [Abstract][Full Text] [Related]
14. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
15. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
16. Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption.
Zhou H; Ikeuchi-Takahashi Y; Hattori Y; Onishi H
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235554
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
[TBL] [Abstract][Full Text] [Related]
18. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
Rai G; Jain SK; Agrawal S; Bhadra S; Pancholi SS; Agrawal GP
Pharmazie; 2005 Feb; 60(2):131-4. PubMed ID: 15739902
[TBL] [Abstract][Full Text] [Related]
19. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J
Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717
[TBL] [Abstract][Full Text] [Related]
20. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
